All Posts

How start-ups can succeed at recruitment in 2023

How start-ups can succeed at recruitment in 2023

  For most start-ups, recruitment is an ongoing and significant challenge. Find..

FINGERPRINTS’ SUPPORTS TWO MORE BIOMETRIC PAYMENT CARD LAUNCHES IN THE MENA REGION

FINGERPRINTS’ SUPPORTS TWO MORE BIOMETRIC PAYMENT CARD LAUNCHES IN THE MENA REGION

World-leading biometrics company, Fingerprint Cards AB (Fingerprints™), has announce..

UK Has 5 Million Hidden Lone Workers

UK Has 5 Million Hidden Lone Workers

  New research shows that 64% of UK employees who regularly work without close ..

Zoom shares down 90% from peak as pandemic boom fades

Zoom shares down 90% from peak as pandemic boom fades

By Aditya Soni and Chavi Mehta (Reuters) – Shares of Zoom Video Communications..

End of cheap money for U.S. farmers plows trouble into food production

End of cheap money for U.S. farmers plows trouble into food production

By P.J. Huffstutter and Bianca Flowers CHICAGO (Reuters) – Montana farmer Sara..

VICTORIAMETRICS AND CMS TEAM UP TO MONITOR THE UNIVERSE AND BEYOND

VICTORIAMETRICS AND CMS TEAM UP TO MONITOR THE UNIVERSE AND BEYOND

NOV 17TH, SAN FRANCISCO: VictoriaMetrics, the open source, time series database moni..

Wall Street seen opening higher but U.S. recession priced in

Wall Street seen opening higher but U.S. recession priced in

By Carolyn Cohn LONDON (Reuters) – U.S. stock index futures rose on Friday, in..

ECB could slow rate hikes, but bond run-off should start soon, Knot says

ECB could slow rate hikes, but bond run-off should start soon, Knot says

FRANKFURT (Reuters) – The European Central Bank may slow the pace of interest ..

After Elon Musk’s ultimatum, Twitter employees start exiting

After Elon Musk’s ultimatum, Twitter employees start exiting

By Sheila Dang, Paresh Dave and Hyunjoo Jin (Reuters) -Hundreds of Twitter Inc emplo..

Pfizer/BioNTech’s updated COVID shot shows strong response against BQ.1.1

Pfizer/BioNTech’s updated COVID shot shows strong response against BQ.1.1

(Reuters) -Pfizer Inc and its German partner BioNTech SE said on Friday their Omicro..